ATS
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
QUICK SEARCH:   [advanced]


     

This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to Personal Folders
Right arrow Download to citation manager
Right arrow Permission Requests
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Marchand, M. A.
Right arrow Articles by David, T. E.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Marchand, M. A.
Right arrow Articles by David, T. E.
Related Collections
Right arrow Valve disease

Ann Thorac Surg 2001;71:S236-S239
© 2001 The Society of Thoracic Surgeons

Valvular bioprostheses over 15 years

Fifteen-year experience with the mitral Carpentier-Edwards PERIMOUNT pericardial bioprosthesis

Michel A. Marchand, MDa, Michel R. Aupart, MDa, Robert Norton, MDb, Ira R.A. Goldsmith, FRCSb, L. Conrad Pelletier, MDc, Michel Pellerin, MDc, Thomas Dubiel, MDd, Willem J. Daenen, MDe, Paul Herijgers, MDe, Filip P. Casselman, MDe, Michael P. Holden, FRCSf, Tirone E. David, MDg

a Department of Cardiothoracic Surgery and Cardiology, Hôpital Trousseau and Francois Rabelais University, Tours, France
b Department of Cardiothoracic Surgery and Cardiology, Walsgrave Hospital, Coventry, United Kingdom
c Department of Cardiothoracic Surgery and Cardiology, Institut de Cardiologie, Montreal, Quebec, Canada
d Department of Cardiothoracic Surgery and Cardiology, University Hospital, Uppsala, Sweden
e Department of Cardiothoracic Surgery and Cardiology, University Hospital, Gasthuisberg, Leuven, Belgium
f Department of Cardiothoracic Surgery and Cardiology, Freeman Hospital, Newcastle Upon Tyne, United Kingdom
g Department of Cardiothoracic Surgery and Cardiology, Toronto General Hospital, Toronto, Ontario, Canada

Address reprint requests to Dr Marchand, Department of Cardiac Surgery, C.H.U. Trousseau, 37044 Tours Cedex 1, France
e-mail: marchand{at}med.univ-tours.fr

Presented at the VIII International Symposium on Cardiac Bioprostheses, Cancun, Mexico, Nov 3–5, 2000.

Background. This multicenter study concerning the mitral PERIMOUNT valve previously reported clinical results at 12 years; this report updates the performance to 15 years postoperatively.

Methods. The 435 patients (mean age 60.7 ± 11.6 years; 41.1% male) underwent implantation with the PERIMOUNT valve between 1984 and 1989 at seven institutions. Follow-up was complete for 96.1% of the cohort. The mean follow-up was 8.1 ± 4.4 years (range 0 to 15.4 years) for a total of 3492 patient-years.

Results. There were 34 (7.8%) operative deaths, one (0.2%) valve related. The late mortality rate was 5.3%/patient-year (2.2%/patient-year valve related). At 14 years, the overall actuarial survival rate was 37.1% ± 3.3% (63.1% ± 4.4% valve related). Actuarial freedom from complications at 14 years was as follows: thromboembolism, 83.8% ± 3.2% (1.1%/patient-year); hemorrhage, 86.6% ± 3.2% (1.1%/patient-year); and explant due to structural valve deterioration (SVD), 68.8% ± 4.7%. Actual freedom from explant due to SVD was 83.4% ± 2.3%. Rates of structural failure decreased with increasing age at implant.

Conclusions. The Carpentier-Edwards PERIMOUNT Pericardial Bioprosthesis is a reliable choice for a tissue valve in the mitral position, especially in patients more than 60 years of age.




This article has been cited by other articles:


Home page
 J Am Coll CardiolHome page
R. O. Bonow, B. A. Carabello, K. Chatterjee, A. C. de Leon Jr, D. P. Faxon, M. D. Freed, W. H. Gaasch, B. W. Lytle, R. A. Nishimura, P. T. O'Gara, et al.
ACC/AHA 2006 Guidelines for the Management of Patients With Valvular Heart Disease: A Report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Writing Committee to Revise the 1998 Guidelines for the Management of Patients With Valvular Heart Disease) Developed in Collaboration With the Society of Cardiovascular Anesthesiologists Endorsed by the Society for Cardiovascular Angiography and Interventions and the Society of Thoracic Surgeons
J. Am. Coll. Cardiol., August 1, 2006; 48(3): e1 - e148.
[Full Text] [PDF]

Home page
 J. Thorac. Cardiovasc. Surg.Home page
W.R. E. Jamieson, L. H. Burr, R. T. Miyagishima, E. Germann, J. S. MacNab, E. Stanford, F. Chan, M. T. Janusz, and H. Ling
Carpentier-Edwards supra-annular aortic porcine bioprosthesis: Clinical performance over 20 years
J. Thorac. Cardiovasc. Surg., October 1, 2005; 130(4): 994 - 1000.
[Abstract] [Full Text] [PDF]

Home page
 Ann. Thorac. Surg.Home page
F. Filsoufi and D. H. Adams
Invited commentary
Ann. Thorac. Surg., July 1, 2004; 78(1): 65 - 66.
[Full Text] [PDF]

Home page
 J. Thorac. Cardiovasc. Surg.Home page
M. L. Polo, J. J. Legarra, M. Vilar, A. Cabrera, D. Duran, and G. Pradas
Early calcification of a Carpentier-Edwards Perimount mitral valve in an elderly woman
J. Thorac. Cardiovasc. Surg., November 1, 2002; 124(5): 1043 - 1044.
[Full Text] [PDF]


HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
ANN THORAC SURG ASIAN CARDIOVASC THORAC ANN EUR J CARDIOTHORAC SURG
J THORAC CARDIOVASC SURG ICVTS ALL CTSNet JOURNALS
Copyright © 2001 by The Society of Thoracic Surgeons.